Dihydropyrimidine dehydrogenase circadian rhythm in mouse liver
- 1 April 2003
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 39 (6), 822-828
- https://doi.org/10.1016/s0959-8049(02)00598-1
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Dihydropyrimidine dehydrogenase deficiency and fluorouracil-related toxicityBritish Journal of Cancer, 1999
- A Serum Shock Induces Circadian Gene Expression in Mammalian Tissue Culture CellsCell, 1998
- Randomised multicentre trial of chronotherapy with oxaliplatin, fluorouracil, and folinic acid in metastatic colorectal cancerThe Lancet, 1997
- Inter- and intraindividual variation in dihydropyrimidine dehydrogenase activity in peripheral blood mononuclear cellsCancer Chemotherapy and Pharmacology, 1997
- A role for dihydropyrimidine dehydrogenase and thymidylate synthase in tumour sensitivity to fluorouracilEuropean Journal Of Cancer, 1994
- Chronomodulated Versus Fixed-Infusion—Rate Delivery of Ambulatory Chemotherapy With Oxaliplatin, Fluorouracil, and Folinic Acid (Leucovorin) in Patients With Colorectal Cancer Metastases: a Randomized Multi-institutional TrialJNCI Journal of the National Cancer Institute, 1994
- Spontaneous or imposed circadian changes in plasma concentrations of 5-fluorouracil coadministered with folinic acid and oxaliplatin: Relationship with mucosal toxicity in patients with cancerClinical Pharmacology & Therapeutics, 1994
- Dihydropyrimidine dehydrogenase activity in cancer patientsEuropean Journal Of Cancer, 1993
- Clinical Pharmacology of 5-FluorouracilClinical Pharmacokinetics, 1989
- Circadian rhythm of rat liver dihydropyrimidine dehydrogenaseBiochemical Pharmacology, 1988